Showing results (1671-1680 of 5,086) with videos related to

Sort By:
Pageof 509
Current Medicinal Chemistry|July 16, 2010
Beta amyloid aggregation inhibitors: small molecules as candidate drugs for therapy of Alzheimer's diseaseF Re, C Airoldi, C Zona, et al.
Tumori|June 30, 1990
Cisplatin and mitomycin C in advanced chemotherapy-refractory breast cancerD Crivellari, E Galligioni, S Frustaci, et al.
Experimental Hematology|June 1, 1990
Early loss of circulating hemopoietic progenitors in HIV-1-infected subjectsG P Bagnara, G Zauli, M Giovannini, et al.
American Heart Journal|November 5, 1997
Renin-angiotensin system: genes to bedsideF S Malik, C J Lavie, M R Mehra, et al.
Molecules (Basel, Switzerland)|August 27, 2021
The Inhibition of Non-<i>albicans Candida</i> Species and Uncommon Yeast Pathogens by Selected Essential Oils and Their Major CompoundsNarcisa Mandras, Janira Roana, Daniela Scalas, et al.
Microbial Pathogenesis|June 21, 2020
Low-dose doxycycline induces Chlamydia trachomatis persistence in HeLa cellsAntonella Marangoni, Chiara Zalambani, Giacomo Marziali, et al.
Organic & Biomolecular Chemistry|October 26, 2019
Tailoring chemoenzymatic oxidation via in situ peracidsRebecca N Re, Johanna C Proessdorf, James J La Clair, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|August 14, 2016
Nanocarriers in cancer clinical practice: a pharmacokinetic issueLuciana Giodini, Francesco Lo Re, Davide Campagnol, et al.
European Urology|January 1, 1996
Multidrug chemotherapy in the treatment of non-elderly patients with hormone-refractory prostatic carcinoma. A phase II study. North-Eastern Italian Oncology Group (GOCCNE)A Veronesi, G L Re, S Foladore, et al.
Scientific Reports|February 28, 2017
Genetic ablation of GINIP-expressing primary sensory neurons strongly impairs Formalin-evoked painLouise Urien, Stéphane Gaillard, Laure Lo Re, et al.
Pageof 509